American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(66), 2022
DOI: 10.1128/aac.00237-22
Full text: Download
Artemisinin-based combination therapies have been crucial in driving down the global burden of malaria, the world’s largest parasitic killer. However, their efficacy is now threatened by the emergence of resistance in Southeast Asia and sub-Saharan Africa.